Patents by Inventor Anil CHHETTRY

Anil CHHETTRY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Delayed Release Compositions of Linaclotide
    Publication number: 20230398173
    Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
    Type: Application
    Filed: August 28, 2023
    Publication date: December 14, 2023
    Inventors: Angelika Fretzen, Mark G. Currie, Ahmad Hashash, Mahendra Dedhiya, Yun Mo, Anil Chhettry, Matthew Miller, Ritesh Sanghvi, Mohammad Mafruhul Bari, Andreas Grill
  • Delayed Release Compositions of Linaclotide
    Publication number: 20230142270
    Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
    Type: Application
    Filed: December 30, 2022
    Publication date: May 11, 2023
    Inventors: Angelika Fretzen, Mark G. Currie, Ahmad Hashash, Mahendra Dedhiya, Yun Mo, Anil Chhettry, Matthew Miller, Ritesh Sanghvi, Mohammad Mafruhul Bari, Andreas Grill
  • STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
    Publication number: 20200253901
    Abstract: The present invention relates to stable dosage forms of levomilnacipran and pharmaceutically acceptable salts thereof. Processes for the preparation of these dosage forms and methods of using these dosage forms are also described.
    Type: Application
    Filed: January 9, 2020
    Publication date: August 13, 2020
    Inventors: Anil Chhettry, Murali Divi, Rahul Surana
  • Micronized colistimethane sodium pharmaceutical compositions
    Patent number: 10441536
    Abstract: Described herein are micronized powder particles of colistimethate sodium wherein at least 50% by volume of the micronized particles have a diameter of less than 7 micrometers but not less than 3 micrometers and the powder has a total moisture content of from 5 to 10% by weight, for use in the treatment of a pulmonary infection by powder inhalation, wherein the colistimethate sodium is not separated into component form. The micronized powder particles of colistimethate sodium are useful in the treatment of infections caused by gram-negative bacteria, particularly in patients suffering from cystic fibrosis.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: October 15, 2019
    Assignee: ACTAVIS GROUP PTC EHF
    Inventors: Richard Anthony Flynn, Rahul Surana, Anil Chhettry, David Farrington, Ritesh Sanghvi
  • STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
    Publication number: 20180028476
    Abstract: The present invention relates to stable dosage forms of levomilnacipran and pharmaceutically acceptable salts thereof. Processes for the preparation of these dosage forms and methods of using these dosage forms are also described.
    Type: Application
    Filed: August 24, 2017
    Publication date: February 1, 2018
    Inventors: Anil Chhettry, Murali Divi, Rahul Surana
  • ORALLY DISSOLVING FORMULATIONS OF MEMANTINE
    Publication number: 20170172942
    Abstract: Orally dissolving formulations, e.g., tablets (ODTs) and films (ODFs) comprising memantine and methods of treating conditions, including childhood behavioral disorders and Alzheimer's disease, by administering orally dissolving formulations are provided. The orally dissolving formulations of the present invention may be used to treat various conditions, but is particularly suited to treat childhood behavioral disorders, such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) and also to treat elderly patients suffering from Alzheimer's disease.
    Type: Application
    Filed: March 6, 2017
    Publication date: June 22, 2017
    Inventors: Shashank Mahashabde, Mahendra G. Dedihya, Anil Chhettry, Ranajoy Sarkar
  • MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
    Publication number: 20160346227
    Abstract: The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain.
    Type: Application
    Filed: August 11, 2016
    Publication date: December 1, 2016
    Inventors: Mahendria G. Dedhiya, Suneel K. Rastogi, Anil Chhettry, Narasimhan Mani, Niranjan Rao, Antonia Periclou
  • Delayed Release Compositions of Linaclotide
    Publication number: 20160310559
    Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
    Type: Application
    Filed: December 11, 2014
    Publication date: October 27, 2016
    Inventors: Angelika Fretzen, Mark G. Currie, Ahmad Hashash, Mahendra Dedhiya, Yun Mo, Anil Chhettry, Matthew Miller, Ritesh Sanghvi, Mohammad Mafruhul Bari, Andreas Grill
  • MICRONIZED PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160022577
    Abstract: Described herein are micronized powder particles of colistimethate sodium wherein at least 50% by volume of the micronized particles have a diameter of less than 7 micrometres but not less than 3 micrometres and the powder has a total moisture content of from 5 to 10% by weight, for use in the treatment of a pulmonary infection by powder inhalation, wherein the colistimethate sodium is not separated into component form. The micronized powder particles of colistimethate sodium are useful in the treatment of infections caused by gram-negative bacteria, particularly in patients suffering from cystic fibrosis.
    Type: Application
    Filed: March 7, 2014
    Publication date: January 28, 2016
    Inventors: Richard Anthony Flynn, Rahul Surana, Anil Chhettry, David Farrington, Ritesh Sanghvi
  • STABLE GLUCOKINASE ACTIVATOR COMPOSITIONS
    Publication number: 20160015638
    Abstract: The invention relates to stable pharmaceutical compositions comprising a glucokinase (GK) activator suitable for oral administration. The invention also relates to methods of making and using such pharmaceutical compositions.
    Type: Application
    Filed: August 31, 2015
    Publication date: January 21, 2016
    Inventors: Yun Mo, Mahendra G. Dedhiya, Anil Chhettry
  • MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
    Publication number: 20150258042
    Abstract: The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain.
    Type: Application
    Filed: May 27, 2015
    Publication date: September 17, 2015
    Inventors: Mahendra G. DEDHIYA, Suneel K. RASTOGI, Anil CHHETTRY, Narasimhan MANI, Niranjan RAO, Antonia PERICLOU
  • Orally Dissolving Formulations of Memantine
    Publication number: 20150238442
    Abstract: Orally dissolving formulations, e.g., tablets (ODTs) and films (ODFs) comprising memantine and methods of treating conditions, including childhood behavioral disorders and Alzheimer's disease, by administering orally dissolving formulations are provided. The orally dissolving formulations of the present invention may be used to treat various conditions, but is particularly suited to treat childhood behavioral disorders, such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) and also to treat elderly patients suffering from Alzheimer's disease.
    Type: Application
    Filed: May 13, 2015
    Publication date: August 27, 2015
    Inventors: Shashank Mahashabde, Mahendra G. Dedhiya, Anil Chhettry, Ranajoy Sarkar
  • Pharmaceutical formulations containing dopamine receptor ligands
    Patent number: 9056846
    Abstract: The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.
    Type: Grant
    Filed: October 17, 2012
    Date of Patent: June 16, 2015
    Assignee: Richter Gedeon Nyrt.
    Inventors: Ranajoy Sarkar, Mahendra G. Dedhiya, Anil Chhettry
  • Pharmaceutical formulations containing dopamine receptor ligands
    Patent number: 9056845
    Abstract: The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.
    Type: Grant
    Filed: July 16, 2009
    Date of Patent: June 16, 2015
    Assignee: Richter Gedeon Nyrt.
    Inventors: Ranajoy Sarkar, Mahendra G. Dedhiya, Anil Chhettry
  • STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
    Publication number: 20150148424
    Abstract: The present invention relates to stable dosage forms of levomilnacipran and pharmaceutically acceptable salts thereof. Processes for the preparation of these dosage forms and methods of using these dosage forms are also described.
    Type: Application
    Filed: January 28, 2015
    Publication date: May 28, 2015
    Inventors: Anil Chhettry, Murali Divi, Rahul Surana
  • CHEMICAL COMPOSITION
    Publication number: 20150148388
    Abstract: The present invention is directed to stable chemical compositions and dosage forms that comprise nebivolol and valsartan and which achieve therapeutically effective plasma levels of both actives in hypertensive patients following administration, as well as to methods of lowering blood pressure and treating hypertension using such compositions and dosage forms.
    Type: Application
    Filed: January 29, 2015
    Publication date: May 28, 2015
    Inventors: Anil Chhettry, Mahendra G. Dedhiya, Kinjal Suchak, Stephan Ortiz, Chun Lin Chen
  • Pharmaceutical formulations containing dopamine receptor ligands
    Patent number: RE47333
    Abstract: The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: April 2, 2019
    Assignee: Richter Gedeon Nyrt.
    Inventors: Ranajoy Sarkar, Mahendra G. Dedhiya, Anil Chhettry
  • Pharmaceutical formulations containing dopamine receptor ligands
    Patent number: RE47350
    Abstract: The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: April 16, 2019
    Assignee: Richter Gedeon Nyrt.
    Inventors: Ranajoy Sarkar, Mahendra G. Dedhiya, Anil Chhettry
  • Pharmaceutical formulations containing dopamine receptor ligands
    Patent number: RE49110
    Abstract: The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: June 21, 2022
    Inventors: Ranajoy Sarkar, Mahendra G. Dedhiya, Anil Chhettry
  • Pharmaceutical formulations containing dopamine receptor ligands
    Patent number: RE49302
    Abstract: The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: November 15, 2022
    Assignee: Richter Gedeon Nyrt.
    Inventors: Ranajoy Sarkar, Mahendra G. Dedhiya, Anil Chhettry